Skip to main content

Dr. William Gradishar, MD

Medical Oncology (Medical Oncology Physician)

675 N Saint Clair St, Galter 21-100
Chicago, IL 60611

Who else practices at this address →

Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas

Call (312) 695-0990

  • Medicare participating

At a glance

Years since graduation
44
In the NPI registry since
2006
Medicare patients seen, 2024
431

Licensed in Illinois since 1983, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1982Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    IL license 036067208 (first issued 1983; active)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
431
Services billed
87,945
Patients’ average age
73
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, denosumab, 1 mg14,64045
Injection, paclitaxel, 1 mg11,89619
Injection, fosaprepitant, 1 mg9,15028
Injection, pembrolizumab, 1 mg8,00013
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg2,45513
Injection, dexamethasone sodium phosphate, 1 mg1,70943
Injection, fulvestrant, 25 mg1,65025
Injection, palonosetron hcl, 25 mcg1,08039
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg62013
Established patient office or other outpatient visit, 30-39 minutes612341

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Anastrozole
Other prescribers in Chicago, IL
300
Tamoxifen Citrate
Other prescribers in Chicago, IL
51
Ibrance (palbociclib)51
Letrozole
Other prescribers in Chicago, IL
49
Exemestane46
Kisqali (ribociclib succinate)35
Truqap (capivasertib)24
Prochlorperazine Maleate
Other prescribers in Chicago, IL
16
Verzenio (abemaciclib)16
Orserdu (elacestrant hcl)12

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 12 companies reported 50 payments worth $56,384 in total to this clinician.

By type
Consulting Fee$51,930
Travel and Lodging$2,070
Food and Beverage$1,204
Speaking at a medical education program$1,180

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 2, 2025E.r. Squibb & Sons, L.l.c.
Oct 2, 2025
Consulting Fee$14,067
Jun 24, 2025AstraZeneca Pharmaceuticals LP
Jun 24, 2025
Consulting Fee$5,740
Jun 11, 2025AstraZeneca Pharmaceuticals LP
Jun 11, 2025
Consulting Fee$4,920
Jun 9, 2025Pfizer Inc.
Jun 9, 2025
Consulting Fee
TUKYSA · ONCOLOGY
$4,675
Jun 6, 2025F. Hoffmann-la Roche AG
Jun 6, 2025
Consulting Fee
Perjeta · BioOncology
$2,870
Feb 11, 2025AstraZeneca Pharmaceuticals LP
Feb 11, 2025
Consulting Fee
Truqap · Oncology
$2,460
Apr 15, 2025AstraZeneca Pharmaceuticals LP
Apr 15, 2025
Consulting Fee
DATROWAY · Oncology
Company’s descriptionResearch Related Service
$2,398
Jun 24, 2025Lilly USA, LLC
Jun 24, 2025
Consulting Fee$2,250
Oct 23, 2025Gilead Sciences, Inc.
Oct 23, 2025
Consulting Fee
Trodelvy · ONC
Company’s description;4253446;VEM US;10195545
$1,820
Apr 28, 2025Genentech, Inc.
Apr 28, 2025
Consulting Fee
Itovebi · BioOncology
$1,804
All 31 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 22, 2025Janssen Research & Development, LLC
Dec 22, 2025
Consulting Fee$575
Oct 31, 2025Stemline Therapeutics Inc.
Oct 31, 2025
Consulting Fee
Orserdu · Oncology
$390
Oct 23, 2025Gilead Sciences, Inc.
Oct 23, 2025
Consulting Fee
Trodelvy · ONC
Company’s description;4253446;VEM US;10195545
$1,820
Oct 18, 2025Gilead Sciences, Inc.
Oct 18, 2025
Travel and Lodging
Trodelvy · ONC · travel to Foster City, CA · in-kind
Company’s description;4253529;VEM US;10195545
$634
Oct 14, 2025Daiichi Sankyo Inc.
Oct 14, 2025
Consulting Fee
Enhertu · ONCOLOGY
$343
Oct 7, 2025E.r. Squibb & Sons, L.l.c.
Oct 7, 2025
Travel and Lodging
travel to BOSTON, MA
$166
Oct 2, 2025E.r. Squibb & Sons, L.l.c.
Oct 2, 2025
Consulting Fee$14,067
Sep 8, 2025Eli Lilly and Company
Sep 8, 2025
Consulting Fee
VERZENIO · Oncology
$900
Sep 3, 2025E.r. Squibb & Sons, L.l.c.
Sep 3, 2025
Travel and Lodging
travel to Boston, MA
$387
Sep 3, 2025E.r. Squibb & Sons, L.l.c.
Sep 3, 2025
Travel and Lodging
travel to Boston, MA
$387
Sep 3, 2025E.r. Squibb & Sons, L.l.c.
Sep 3, 2025
Travel and Lodging
travel to Boston, MA
$37.74
Sep 2, 2025E.r. Squibb & Sons, L.l.c.
Sep 2, 2025
Travel and Lodging
travel to Boston, MA
$387
Jul 23, 2025AstraZeneca Pharmaceuticals LP
Jul 23, 2025
Consulting Fee
ENHERTU · Oncology
$820
Jul 15, 2025Janssen Research & Development, LLC
Jul 15, 2025
Consulting Fee$575
Jun 24, 2025AstraZeneca Pharmaceuticals LP
Jun 24, 2025
Consulting Fee$5,740
Jun 24, 2025Lilly USA, LLC
Jun 24, 2025
Consulting Fee$2,250
Jun 18, 2025Eli Lilly and Company
Jun 18, 2025
Consulting Fee
Company’s descriptionSERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES
$900
Jun 14, 2025Tolmar, Inc.
Jun 14, 2025
Consulting Fee
OVELIA · Endocrinology
$1,800
Jun 11, 2025AstraZeneca Pharmaceuticals LP
Jun 11, 2025
Consulting Fee$4,920
Jun 9, 2025Pfizer Inc.
Jun 9, 2025
Consulting Fee
TUKYSA · ONCOLOGY
$4,675
Jun 9, 2025AstraZeneca Pharmaceuticals LP
Jun 9, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionConsulting Expenses
$38.60
Jun 9, 2025AstraZeneca Pharmaceuticals LP
Jun 9, 2025
Travel and Lodging
travel to Chicago, IL
Company’s descriptionConsulting Expenses
$31.78
Jun 6, 2025F. Hoffmann-la Roche AG
Jun 6, 2025
Consulting Fee
Perjeta · BioOncology
$2,870
May 23, 2025Stemline Therapeutics Inc.
May 23, 2025
Consulting Fee
Orserdu · Oncology
$390
May 20, 2025Genentech, Inc.
May 20, 2025
Consulting Fee$990
Apr 28, 2025Genentech, Inc.
Apr 28, 2025
Consulting Fee
Itovebi · BioOncology
$1,804
Apr 22, 2025Gilead Sciences, Inc.
Apr 22, 2025
Consulting Fee
Trodelvy · ONC
Company’s description;4148977;VEM US;10195545
$730
Apr 15, 2025AstraZeneca Pharmaceuticals LP
Apr 15, 2025
Consulting Fee
DATROWAY · Oncology
Company’s descriptionResearch Related Service
$2,398
Mar 13, 2025Daiichi Sankyo Inc.
Mar 13, 2025
Consulting Fee
Enhertu · ONCOLOGY
$514
Feb 14, 2025AstraZeneca Pharmaceuticals LP
Feb 14, 2025
Speaking at a medical education program$1,180
Feb 11, 2025AstraZeneca Pharmaceuticals LP
Feb 11, 2025
Consulting Fee
Truqap · Oncology
$2,460

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Illinois →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $176,141 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Medical Oncology clinicians in Chicago

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 17, 2009), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1437187929. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.